Brazil Approves Final Tests For J&J COVID-19 Vaccine

Brazilian Health Regulators have said they had approved Johnson & Johnson’s experimental vaccine against the Coronavirus pandemic for the final stage of clinical trials, the fourth vaccine to receive widespread testing in the hard-hit Country.

The Health Regulator Anvisa said in a statement that the US pharmaceutical Company’s subsidiary Janssen will test the vaccine on 7,000 volunteers across seven States in Brazil, part of a group of up to 60,000 worldwide.

It said the test would be a randomized, controlled, double-blind Phase 3 trial, or large-scale testing on humans, the last step before regulatory approval.

Brazil has become a key testing ground in the search for a vaccine against COVID-19 since the virus is still spreading fast in the Country.


Related post

Leave a Reply

%d bloggers like this: